期刊文献+
共找到2篇文章
< 1 >
每页显示 20 50 100
Sphincter preservation for distal rectal cancer - a goal worth achieving at all costs? 被引量:2
1
作者 Jürgen Mulsow des c winter 《World Journal of Gastroenterology》 SCIE CAS CSCD 2011年第7期855-861,共7页
To assess the merits of currently available treatment options in the management of patients with low rectal cancer, a review of the medical literature pertaining to the operative and non-operative management of low re... To assess the merits of currently available treatment options in the management of patients with low rectal cancer, a review of the medical literature pertaining to the operative and non-operative management of low rectal cancer was performed, with particular emphasis on sphincter preservation, oncological outcome, functional outcome, morbidity, quality of life, and patient preference. Low anterior resection (AR) is technically feasible in an increasing proportion of patients with low rectal cancer. The cost of sphincter preservation is the risk of morbidity and poor functional outcome in a significant proportion of patients. Transanal and endoscopic surgery are attractive options in selected patients that can provide satisfactory oncological outcomes while avoiding the morbidity and functional sequelae of open total mesorectal excision. In complete responders to neo-adjuvant chemoradiotherapy, a non-operative approach may prove to be an option. Abdominoperineal excision (APE) imposes a permanent stoma and is associated with significant incidence of perineal morbidity but avoids the risk of poor functional outcome following AR. Quality of life following AR and APE is comparable. Given the choice, most patients will choose AR over APE, however patients following APE positively appraise this option. In striving toward sphincter preservation the challenge is not only to achieve the best possible oncological outcome, but also to ensure that patients with low rectal cancer have realistic and accurate expectations of their treatment choice so that the best possible overall outcome can be obtained by each individual. 展开更多
关键词 直肠癌 括约肌 肛门 远端 审查管理 治疗方案 生活质量 发病率
下载PDF
Amiodarone hepatotoxicity complicating obstructive jaundice due to ampullary cancer 被引量:1
2
作者 Anne M collins des c winter +2 位作者 Aidan P Mccormick David c cottell Justin G Geoghegan 《Hepatobiliary & Pancreatic Diseases International》 SCIE CAS 2007年第4期435-437,共3页
BACKGROUND:The presence of dual pathology can cause diagnostic dilemmas. We present a case of adenocarcinoma of the ampulla of Vater with concurrent amiodarone hepatotoxicity. METHODS:Painless jaundice associated with... BACKGROUND:The presence of dual pathology can cause diagnostic dilemmas. We present a case of adenocarcinoma of the ampulla of Vater with concurrent amiodarone hepatotoxicity. METHODS:Painless jaundice associated with a palpable gallbladder was investigated clinically,radiologically endoscopically and via liver biopsy. RESULTS:Liver biopsy showed amiodarone hepatotoxicity Endoscopic biopsy identified an ampullary adenoma However,the endoscopic ultrasound and intra-operative findings suggested a malignancy,which was confirmed postoperatively. CONCLUSIONS:While the classic findings of Courvoisier’s Law are borne out in this case,the etiology of jaundice is twofold. Although dual pathology is uncommon it should always be considered. 展开更多
关键词 ampulla of Vater ADENOCARCINOMA amiodarone hepatotoxicity dual pathology
下载PDF
上一页 1 下一页 到第
使用帮助 返回顶部